Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

22.04.2024

1 Am J Respir Crit Care Med
4 Ann Intern Med
2 BMJ
1 Clin Infect Dis
1 Infect Control Hosp Epidemiol
8 Int J Infect Dis
1 J Infect
8 J Med Virol
1 J Travel Med
6 J Virol
2 Lancet Infect Dis
2 MMWR Morb Mortal Wkly Rep
3 Nature
1 Science



    Am J Respir Crit Care Med

  1. ATRAMONT A, Martin GL, Singer M, Tajahmady A, et al
    One-Year Survival and Hospital-free Days in Critical Illness After Viral Pneumonia.
    Am J Respir Crit Care Med. 2024;209:1019-1022.
    >> Share


    Ann Intern Med

  2. WEITZ HH, Merli GJ
    Annals Consult Guys - COVID-19 and Surgery: A Postpandemic Update.
    Ann Intern Med. 2024;177:eW240001.
    >> Share

  3. ALHAMMADI A, Alshawaf R, Chavda S, Ramondino S, et al
    Infectious Diseases: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0679.
    >> Share

  4. COSCHI CH, Dodbiba L, Guerry D
    Oncology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0520.
    >> Share

  5. ALHABOBI AAM, Almutairi AMS, Bohemid DASY, Sehgal AR, et al
    Nephrology: What You May Have Missed in 2023.
    Ann Intern Med. 2024 Apr 16. doi: 10.7326/M24-0605.
    >> Share


    BMJ

  6. COLLINS GS, Moons KGM, Dhiman P, Riley RD, et al
    TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.
    BMJ. 2024;385:e078378.
    >> Share

  7. MAHASE E
    Covid-19: Charities question inquiry's "refusal" to fully examine mental health impact.
    BMJ. 2024;385:q852.
    >> Share


    Clin Infect Dis


  8. Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.
    Clin Infect Dis. 2024 Apr 15:ciae165. doi: 10.1093.
    >> Share


    Infect Control Hosp Epidemiol

  9. BUCHANAN MO, Sickbert-Bennett EE, Selimos A, Dean SM, et al
    Strategies to maintain an N95 respirator supply during a pandemic supply-chain shortage.
    Infect Control Hosp Epidemiol. 2024;45:688-689.
    >> Share


    Int J Infect Dis

  10. SLURINK IAL, van den Houdt SCM, Mertens G
    Who develops long COVID? Longitudinal pre-pandemic predictors of long COVID and symptom clusters in a representative Dutch population.
    Int J Infect Dis. 2024 Apr 10:107048. doi: 10.1016/j.ijid.2024.107048.
    >> Share

  11. VERGORI A, Lepri AC, Chiuchiarelli M, Mazzotta V, et al
    Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era.
    Int J Infect Dis. 2024 Apr 11:107042. doi: 10.1016/j.ijid.2024.107042.
    >> Share

  12. CHEN H, Yu L, Wang L, Zhang J, et al
    Demographic characteristics and risk factors for invasive fungal sinusitis in the context of COVID-19: A systematic review and meta-analysis.
    Int J Infect Dis. 2024 Apr 11:107054. doi: 10.1016/j.ijid.2024.107054.
    >> Share

  13. LIEW YX, Ho AYL, Wong GC, Chung SJ, et al
    A retrospective study of intravenous pentamidine for PCP prophylaxis in adult patients with hematological malignancies - its utility during respiratory virus pandemics.
    Int J Infect Dis. 2024 Apr 12:107059. doi: 10.1016/j.ijid.2024.107059.
    >> Share

  14. GRONING R, Walde J, Ahlm C, Forsell MN, et al
    Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: a retrospective cohort study.
    Int J Infect Dis. 2024 Apr 12:107046. doi: 10.1016/j.ijid.2024.107046.
    >> Share

  15. GLASER N, Diexer S, Klee B, Purschke DO, et al
    The contribution of SARS-CoV-2 to the burden of acute respiratory infections in winter season 2022/2023: Results from the DigiHero study.
    Int J Infect Dis. 2024 Apr 15:107057. doi: 10.1016/j.ijid.2024.107057.
    >> Share

  16. RICCIO MD, Caini S, Bonaccorsi G, Lorini C, et al
    Global analysis of respiratory viral circulation and timing of epidemics in the pre-COVID-19 and COVID-19 pandemic eras, based on data from the Global Influenza Surveillance and Response System (GISRS).
    Int J Infect Dis. 2024 Apr 16:107052. doi: 10.1016/j.ijid.2024.107052.
    >> Share

  17. GRIFFITHS M, Hatabah D, Sullivan P, Mantus G, et al
    Incidence of SARS-CoV-2 Seropositivity in Pediatric Healthcare Workers Prior to Widespread Vaccination: A Five-month Longitudinal Cohort Study.
    Int J Infect Dis. 2024 Apr 17:107064. doi: 10.1016/j.ijid.2024.107064.
    >> Share


    J Infect

  18. CHUN JY, Jeong SJ, Kim S, Choi S, et al
    Performance of the Galactomannan Test for the Diagnosis of Invasive Pulmonary Aspergillosis using Non-invasive Proximal Airway Samples.
    J Infect. 2024 Apr 17:106159. doi: 10.1016/j.jinf.2024.106159.
    >> Share


    J Med Virol

  19. MENG H, Wang Y, Zhai Y, Luo W, et al
    Unveiling the micronutrient-immunity puzzle in inactivated COVID-19 vaccination: A comprehensive analysis of circulating micronutrient levels and humoral responses in healthy adults.
    J Med Virol. 2024;96:e29611.
    >> Share

  20. MAHLA RS, Dustin LB
    COVID-19 vaccination and autoimmunity: Do we need more evidence?
    J Med Virol. 2024;96:e29623.
    >> Share

  21. WEI M, Li S, Lu X, Hu K, et al
    Changing respiratory pathogens infection patterns after COVID-19 pandemic in Shanghai, China.
    J Med Virol. 2024;96:e29616.
    >> Share

  22. OKITSU S, Khamrin P, Hikita T, Onda Y, et al
    Remarkable increase in the detection and molecular characterization of adenovirus F41 in children with acute gastroenteritis in Japan, 2017-2023.
    J Med Virol. 2024;96:e29615.
    >> Share

  23. MATUSALI G, Vergori A, Cimini E, Mariotti D, et al
    Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV.
    J Med Virol. 2024;96:e29598.
    >> Share

  24. CHEN IW, Weng HL, Lai YC, Hung KC, et al
    Incidence of fatigue 2 years after SARS-CoV-2 infection: An updated meta-analysis and subgroup analysis.
    J Med Virol. 2024;96:e29619.
    >> Share

  25. DESTREMAU M, Chaussade H, Hemar V, Beguet M, et al
    Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: A retrospective multicenter study.
    J Med Virol. 2024;96:e29603.
    >> Share

  26. SUN Q, Gao J, An R, Wang M, et al
    Probing molecular pathways: Illuminating the connection between COVID-19 and Alzheimer's disease through the endocannabinoid system dynamics.
    J Med Virol. 2024;96:e29590.
    >> Share


    J Travel Med

  27. WARDLE J, Bhatia S, Cori A, Nouvellet P, et al
    Temporal variations in international air travel: implications for modelling the spread of infectious diseases.
    J Travel Med. 2024 Mar 17:taae062. doi: 10.1093.
    >> Share


    J Virol

  28. HAN Y, Yuan Z, Yi Z
    Identification of a membrane-associated element (MAE) in the C-terminal region of SARS-CoV-2 nsp6 that is essential for viral replication.
    J Virol. 2024 Apr 19:e0034924. doi: 10.1128/jvi.00349.
    >> Share

  29. PEREZ DR
    A devastating blow: personal reflections on Argentina's scientific decline.
    J Virol. 2024 Apr 16:e0054924. doi: 10.1128/jvi.00549.
    >> Share

  30. EBRIGHT RH, MacIntyre R, Dudley JP, Butler CD, et al
    Implementing governmental oversight of enhanced potential pandemic pathogen research.
    J Virol. 2024;98:e0023724.
    >> Share

  31. TAKADA K, Orba Y, Kida Y, Wu J, et al
    Genes involved in the limited spread of SARS-CoV-2 in the lower respiratory airways of hamsters may be associated with adaptive evolution.
    J Virol. 2024 Apr 16:e0178423. doi: 10.1128/jvi.01784.
    >> Share

  32. WANG X, Qiu W, Hu G, Diao X, et al
    NS7a of SADS-CoV promotes viral infection via inducing apoptosis to suppress type III interferon production.
    J Virol. 2024 Apr 16:e0031724. doi: 10.1128/jvi.00317.
    >> Share

  33. ISHIMARU H, Nishimura M, Shigematsu H, Marini MI, et al
    Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein.
    J Virol. 2024 Apr 16:e0041624. doi: 10.1128/jvi.00416.
    >> Share


    Lancet Infect Dis


  34. Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet Infect Dis. 2024 Apr 16:S1473-3099(24)00158.
    >> Share


  35. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.
    Lancet Infect Dis. 2024 Apr 15:S1473-3099(24)00176.
    >> Share


    MMWR Morb Mortal Wkly Rep

  36. FRANKLIN D, Barbre K, Rowe TA, Reses HE, et al
    COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:339-344.
    >> Share

  37. ZAMBRANO LD, Newhams MM, Simeone RM, Payne AB, et al
    Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:330-338.
    >> Share


    Nature

  38. DOLGIN E
    mRNA drug offers hope for treating a devastating childhood disease.
    Nature. 2024;628:248.
    >> Share

  39. KOZLOV M
    US COVID-origins hearing puts scientific journals in the hot seat.
    Nature. 2024 Apr 16. doi: 10.1038/d41586-024-01129.
    >> Share

  40. LADYZHETS B
    What toilets can reveal about COVID, cancer and other health threats.
    Nature. 2024;628:492-494.
    >> Share


    Science

  41. COUZIN-FRANKEL J
    Lessons in persistence.
    Science. 2024;384:150-154.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016